{"id":"W2030869855","doi":"10.1016/j.bbmt.2008.11.011","title":"Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma","year":2009,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; Otsuka Pharmaceutical; Astellas Pharma; Therakos; Kiadis Pharma; Association of Medical Microbiology and Infectious Disease Canada; American Society for Blood and Marrow Transplantation; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; CellGenix; Medical College of Wisconsin; StemCyte; Enzon Pharmaceuticals; U.S. Navy; Centers for Disease Control and Prevention; Celgene; Osiris Therapeutics; Pfizer; Baxter International; Amgen; Blue Cross and Blue Shield Association; U.S. Department of Health and Human Services; Astellas Pharma US; Bayer HealthCare; U.S. Public Health Service; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Refractory (planetary science); Transplantation; Hematopoietic stem cell transplantation; Salvage therapy; Lymphoma; Cumulative incidence; Regimen; Incidence (geometry); Surgery; Oncology; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009239431,0.00009943157,0.0002356017,0.0002427975,0.0001120077,0.0002445271,0.0002205037,0.0001333544,0.0007587062],"category_scores_gemma":[0.001208234,0.00006096878,0.000260452,0.000303208,0.0002313138,0.0002149103,0.0002186051,0.0002363575,0.0002130035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003000917,"about_ca_system_score_gemma":0.0002918076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00057422,"about_ca_topic_score_gemma":0.0009975729,"domain_scores_codex":[0.9997274,0.0001483833,0.00002097418,0.00002438762,0.00004787051,0.0000308629],"domain_scores_gemma":[0.9994491,0.0001659592,0.0001929768,0.00004636133,0.00001903026,0.0001265341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004474907,0.0005106032,0.8984004,0.0001584276,0.0002768205,0.0009444151,0.0001146906,0.0008342919,0.002657764,0.0001125976,0.0007593576,0.09075577],"study_design_scores_gemma":[0.0003327477,0.004113783,0.989041,0.00003427664,0.0001739548,0.00200923,0.0001096969,0.001356655,0.00118548,0.0002979413,0.001338043,0.000007156639],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983268,0.001136809,0.0001966036,0.00005653902,0.000006917947,0.00001389257,0.00006426555,0.000004202659,0.0001939495],"genre_scores_gemma":[0.9989215,0.0005583069,0.000132585,0.00005655123,0.00002377133,0.000005874621,0.0002140226,0.000001607143,0.00008569883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009239431,"threshold_uncertainty_score":0.004886329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192367320585125,"score_gpt":0.2393056938962956,"score_spread":0.2273820206904444,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}